IBT Laboratories Expands Its Menu Of Tests For Immune Deficiency

IBT Laboratories, a leading clinical-diagnostics and biomedical-research laboratory specializing in immunology and allergy assays, announced that it has launched two tests to evaluate the response of patients whose immune systems may be compromised due to a primary immunodeficiency disorder, chemotherapy drugs, or because they are taking immuno-suppressing drugs to prevent rejection of a transplant.

More: continued here

Filed under: Conferences on December 4th, 2008